Notice is hereby given that the Office of Research Integrity (ORI) has made final findings of scientific misconduct in the following case: Cathy Q. Lee, Massachusetts General Hospital: On February 28, 1996, ORI found that Cathy Q. Lee, Ph.D., Postdoctoral Fellow, Molecular Endocrinology Laboratory at the Massachusetts General Hospital, committed scientific misconduct by engaging in falsification and fabrication of research data incorporated in a manuscript prepared for submission (but not submitted) to the EMBO Journal (Lee, C.Q., Yun, Y., and Habener, J.F. \`\`Transactivation of functions of cAMP-responsive transcription factor CREB-327 mediated by amphiphatic helical domains flanking the requisite serine-119 phosphorylated by protein kinase- A.\'\') and by engaging in improper data selection and falsification of data published in the EMBO Journal (Lee, C.Q., Yun, Y., Hoeffler, J.P., and Habener, J.F. \`\`Cyclic-AMP responsive transcriptional activation of CREB-327 involves interdependent phosphorylated subdomains.\'\' EMBO Journal 9:4455-4465, 1990.). This research was supported by a Public Health Service grant. Dr. Lee has entered into a Voluntary Exclusion Agreement with ORI in settlement of ORI\'s finding of scientific misconduct and has agreed: (1) To exclude herself voluntarily from any contracting or subcontracting with any agency of the United States Government and from eligibility for, or involvement in, Federal nonprocurement transactions (e.g., grants and cooperative agreements) of the United States Government, as defined in 45 C.F.R. Part 76 and 48 C.F.R. Subparts 9.4 and 309.4 (Debarment Regulations) for a period of two (2) years beginning on February 28, 1996; the above voluntary exclusion, however, shall not apply to Dr. Lee\'s future clinical laboratory training or practice, unless that training or practice involves research or research training; (2) That for a period of one (1) year beginning immediately after the two (2) year voluntary exclusion above, any institution that submits an application for PHS support for a research project on which the Respondent\'s participation is proposed or which uses the Respondent in any capacity on PHS supported research, must concurrently submit a plan for supervision of the Respondent\'s duties; the supervisory plan must be designed to ensure the scientific integrity of the Respondent\'s research contribution, and the institution must submit a copy of the supervisory plan to ORI; and (3) To exclude herself voluntarily from serving in any advisory capacity to PHS, including but not limited to service on any PHS advisory committee, board, and/or peer review committee, or as a consultant for a period of three (3) years beginning on February 28, 1996. A letter retracting the article entitled \`\`Cyclic-AMP responsive transcriptional activation of CREB-327 involves interdependent phosphorylated subdomains\'\' (EMBO Journal 9:4455-4465, 1990) has been published in the EMBO Journal (EMBO Journal 13:2736, 1994).
